| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |